CancerConnect
Top Stories
Newly Diagnosed
Treatment & Care
Survivorship

The CancerConnect Ovarian Cancer Newsletter

TraceyS

Stay Current With Ovarian Cancer Treatment Advances & Connect with Others

CancerConnect Ovarian Cancer Newsletter

CancerConnect publishes daily cancer news, original articles and "tips" on the management of Ovarian Cancer. These are available in our monthly Ovarian Cancer newsletter.

Stay Current - Connect With Other Ovarian Cancer Patients

Join The CancerConnect Community: Connect with others and receive regular updates

or

Sign up for the Ovarian Cancer Newsletter Here

Comments

Ovarian Cancer

FEATURED
COMMUNITY

Identifying and Understanding Ovarian Cancer

Ovarian cancer symptoms, risk factors, and treatment

Cancer Connect

Overview of Ovarian Cancer

Understand the symptoms, risk factors, diagnosis, tests and the role of screening and early detection of ovarian cancer.

Cancer Connect

by

Samreen

It’s in the Genes: Genetic Testing for Ovarian Cancer

Understand the role of genetic and genomic testing for individuals with ovarian cancer and their families.

Cancer Connect

Lynparza Delays Progression & Significantly Prolongs Survival in Ovarian Cancer

5 Year follow up data - Lynparza maintenance therapy effective for women with BRCA + and other mutated ovarian cancers.

Cancer Connect

The CA 125 “tumor associated protein” or “tumor marker”

Answers to frequently asked questions about CA 125.

MedMaven

by

gavmankel25

Interleukin-2 Plus Retinoic Acid Improve Outcomes for Recurrent Ovarian Cancer

Interleukin-2 Plus Retinoic Acid May Improve Outcomes for Recurrent Ovarian Cancer

Cancer Connect

Maintenance Therapy for Advanced Ovarian Cancer

PARPs and Avastin delay progression when used as maintenance therapy for certain individuals with ovarian cancer.

Cancer Connect

by

namanjohnson101

Immunotherapy in Ovarian Cancer Treatment: Is More Better, or Just More?

Dual immunotherapy appears promising in clear cell ovarian cancer - additional research warranted.

MedMaven

September Is National Ovarian Cancer Awareness Month

Advances in the management of Ovarian Cancer continue to improve treatment.

Cancer Connect

Zejula (Niraparib) Improves Progression-Free Survival in Ovarian Cancer

The PARP inhibitor Zejula is a precision cancer medicine that delays ovarian cancer progression and prolongs survival.

Cancer Connect